<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02865564</url>
  </required_header>
  <id_info>
    <org_study_id>UPKLjubljana</org_study_id>
    <nct_id>NCT02865564</nct_id>
  </id_info>
  <brief_title>Effect of Lactobacillus Reuteri DSM17938 in Neonates Treated With Antibiotics</brief_title>
  <official_title>Effect of Lactobacillus Reuteri DSM17938 in Neonates Treated With Antibiotics on Emergence of Functional Gastrointestinal Disorders, Body Composition, Mineral Bone Density and Fecal Microbiota in Infancy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Medical Centre Ljubljana</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Ljubljana</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Medical Centre Ljubljana</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to elucidate the relationship between postnatal antibiotic
      administration on development of gut microbiota and possible protective influence of
      simultaneously administration of probiotic during antibiotic therapy on development of gut
      microbiota, functional gastrointestinal disorders of infancy, weight gain and body
      composition.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study is double-blind, placebo-controlled randomised trial and is composed from two
      parts. First part of the study aims to examine any difference in gut microbiota after
      postnatal antibiotic administration between the neonates who received probiotic Lactobacillus
      reuteri DSM 17938 or placebo and to compare the gut microbiota of patients to microbiota of
      healthy newborns. Second part of the study aims to determine whether probiotic L. reuteri DSM
      17938 supplementation to antibiotic therapy has any beneficial influence on incidence of
      functional gastrointestinal disorders of infancy and body composition and bone density 6
      weeks and one year after inclusion in the study.

      Additionally the associations of the clinical parameters with the composition and
      developmental characteristics of fecal microbiota during antibiotic treatment in children
      will be evaluated; relevant clinical data such as mode of delivery, child's nutrition, health
      problems, growth and developmental attributes which could be found associated with fecal
      microbial community, will be tracked and statistically evaluated for the investigated
      population.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 2016</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Functional gastrointestinal dysfunction</measure>
    <time_frame>At 6 months of age</time_frame>
    <description>Questionnaire [/]</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Composition of gut microbiota in infants - 1</measure>
    <time_frame>At 6 weeks after intervention</time_frame>
    <description>[colony-forming units/ml; /]</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Infants crying duration time</measure>
    <time_frame>At 6 months of age</time_frame>
    <description>Questionnaire [/]</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Composition of gut microbiota in infants - 2</measure>
    <time_frame>At one year of age</time_frame>
    <description>[colony-forming units/ml; /]</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Infant weight - 1</measure>
    <time_frame>At 6 months of age</time_frame>
    <description>[kg]; to calculate body mass index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bone mineral density in infants - 1</measure>
    <time_frame>At 6 months of age</time_frame>
    <description>Z-score [/]</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Infant height - 1</measure>
    <time_frame>At 6 months of age</time_frame>
    <description>[m]; to calculate body mass index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Infant weight - 2</measure>
    <time_frame>At 12 months of age</time_frame>
    <description>[kg]; to calculate body mass index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bone mineral density in infants - 2</measure>
    <time_frame>At 12 months of age</time_frame>
    <description>Z-score [/]</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Infant height - 2</measure>
    <time_frame>At 12 months of age</time_frame>
    <description>[m]; to calculate body mass index</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body composition of infants - 1</measure>
    <time_frame>At 6 months of age</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body composition of infants - 2</measure>
    <time_frame>At 12 months of age</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Gastrointestinal Diseases</condition>
  <condition>Colic</condition>
  <arm_group>
    <arm_group_label>Intervention group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The intervention group will receive 5 drops, a minimum of 100 million live Lactobacillus reuteri DSM 17938 a day during antibiotic treatment (empirical treatment for neonatal sepsis with ampicillin and gentamicin) and 6 consecutive weeks after finishing the antibiotic treatment.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo group will receive 5 drops of maltodextrin in the some oil suspension a day during antibiotic treatment (empirical treatment for neonatal sepsis with ampicillin and gentamicin) and 6 consecutive weeks after finishing the antibiotic treatment.</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Lactobacillus reuteri DSM 17938</intervention_name>
    <arm_group_label>Intervention group</arm_group_label>
    <other_name>BioGaia</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <arm_group_label>Placebo group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>ampicillin and gentamicin</intervention_name>
    <arm_group_label>Intervention group</arm_group_label>
    <arm_group_label>Placebo group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  term neonates whom antibiotic treatment will be introduced due to clinical suspicion
             of infection

        Exclusion Criteria:

          -  gestational age under 37 weeks

          -  birth weight less than 2500 grams

          -  congenital malformations/syndromes

          -  perinatal hypoxia

          -  who had received probiotics before the randomization

          -  have had cow's milk protein allergy diagnosed during the study

          -  patient who will be treated with antibiotic for less than 5 days
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>21 Days</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jana Lozar Krivec, MD</last_name>
    <phone>0038615224064</phone>
    <email>jana.lozar@guest.arnes.si</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Evgen Benedik, PhD</last_name>
    <phone>0038615223739</phone>
    <email>evgen.benedik@kclj.si</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Medical Centre Ljubljana</name>
      <address>
        <city>Ljubljana</city>
        <zip>1000</zip>
        <country>Slovenia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jana Lozar Krivec, MD</last_name>
      <phone>0038615224064</phone>
      <email>jana.krivec@guest.arnes.si</email>
    </contact>
  </location>
  <location_countries>
    <country>Slovenia</country>
  </location_countries>
  <verification_date>December 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 4, 2016</study_first_submitted>
  <study_first_submitted_qc>August 11, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 12, 2016</study_first_posted>
  <last_update_submitted>December 7, 2017</last_update_submitted>
  <last_update_submitted_qc>December 7, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">December 8, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Medical Centre Ljubljana</investigator_affiliation>
    <investigator_full_name>Jana Lozar Krivec</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <keyword>Probiotics</keyword>
  <keyword>Anti-Bacterial Agents</keyword>
  <keyword>Infant, Newborn</keyword>
  <keyword>Gastrointestinal Microbiome</keyword>
  <keyword>Colic</keyword>
  <keyword>Gastrointestinal Diseases</keyword>
  <keyword>Body Composition</keyword>
  <keyword>Bone Density</keyword>
  <keyword>Randomized Controlled Trial</keyword>
  <keyword>Lactobacillus reuteri</keyword>
  <keyword>Pediatrics</keyword>
  <keyword>Feces</keyword>
  <keyword>ultrasonography</keyword>
  <keyword>High-Throughput Nucleotide Sequencing</keyword>
  <keyword>Electric Impedance</keyword>
  <keyword>Surveys and Questionnaires</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gastrointestinal Diseases</mesh_term>
    <mesh_term>Digestive System Diseases</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anti-Bacterial Agents</mesh_term>
    <mesh_term>Gentamicins</mesh_term>
    <mesh_term>Ampicillin</mesh_term>
    <mesh_term>Antibiotics, Antitubercular</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

